tirzepatide news https://t.co/QYMeNhMdZk Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease Pioglitazone with SGLT2 inhibitors Quantity:Full Case (12 Bottles) market_latam

tirzepatide news https://t.co/QYMeNhMdZk Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease Pioglitazone with SGLT2 inhibitors Quantity:Full Case (12 Bottles) market_latam

Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes?

Also, in October 2024, in the functional food and supplement area, Supergut set in motion its GLP-1 supportive bars and shakes that contain high levels of resistant starch and inulin

market_latam

Quantity:Full Case (12 Bottles)

Explore our supportive supplements, like GLP-1 Daily Support, to help manage your routine